Delivery Order SPE2DB22D6029-SPE2DB25FLWBK
- Not listed
- The Defense Logistics Agency awarded a $51,089.97 delivery order to AmerisourceBergen Drug Corp for Revlimid 10 mg capsules (28-count) on September 9, 2025, with performance completion targeted for September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $27,425.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Revlimid 2.5 mg capsules (28-count units), with an ultimate completion date of September 29, 2025. This non-set-aside competitive award was issued on September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Revlimid 10 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $52,575.49 and an ultimate completion date of September 26, 2025. This is a competitively awarded, non-set-aside delivery order issued to support federal medical procurement needs. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency has awarded a delivery order valued at $48,095.44 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count packages). This firm fixed-price, competitively awarded delivery order is scheduled for completion by October 20, 2025, with the product being delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Revlimid 10 mg capsules (28-count package) with a ceiling value of $102,180.00. This firm fixed-price delivery order, which is expected to be completed by September 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a $1.34 million delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Revlimid 10 mg capsules (100-count units). This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive process and scheduled for completion by October 20, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $147,872 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Revlimid 10 mg capsules (28-count packages). This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a $51,879.46 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Revlimid 5 mg capsules (100-count units). This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award utilizes no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal...
- The Defense Logistics Agency awarded a delivery order valued at $25,840.56 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) under a firm fixed price contract. The award, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and will fulfill...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25.8K to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (quantity: 28 units) on August 14, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLWBKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $97,728.21 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on September 19, 2025, with an ultimate completion date of October 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor supplying a broad portfolio of brand-name and generic medications, vaccines, and specialized medical commodities to the Defense Health Agency and other government healthcare systems. The company's extensive federal contract history demonstrates its capability to fulfill diverse pharmaceutical needs through open competition. This delivery order for Revlimid, a specialty pharmaceutical used in oncology and hematology applications, exemplifies the company's role in supporting military medical supply requirements through the DLA's global pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $97.7k | 9/19/25 |